CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

被引：24

作者：

Barragan, Eva ^{[1
,2
]}

Chillon, Maria Carmen ^{[3
]}

Castello-Cros, Remedios ^{[4
]}

Marcotegui, Nerea ^{[4
]}

Prieto, Maria Isabel ^{[3
]}

Hoyos, Montserrat ^{[5
]}

Pippa, Raffaella ^{[4
]}

Llop, Marta ^{[1
,2
]}

Etxabe, Amaia ^{[4
]}

Cervera, Jose ^{[1
,2
]}

Rodriguez, Gabriela ^{[6
]}

Buno, Ismael ^{[6
]}

Rifon, Jose ^{[7
]}

Sierra, Jorge ^{[5
]}

Gonzalez, Marcos ^{[3
]}

Calasanz, Maria J. ^{[8
]}

Sanz, Miguel A. ^{[1
,2
]}

Odero, Maria D. ^{[4
,8
]}

机构：

[1] Univ Hosp La Fe, Clin Lab, Valencia, Spain

[2] Univ Hosp La Fe, Dept Hematol, Valencia, Spain

[3] Univ Hosp Salamanca, Salamanca Inst Biomed Res IBSAL, Salamanca, Spain

[4] Univ Navarra, CIMA, Program Hematol Oncol, E-31080 Pamplona, Spain

[5] Hosp Santa Creu & Sant Pau, Dept Hematol, E-08025 Barcelona, Spain

[6] Gregorio Maranon Inst Hlth Res, Dept Hematol, Madrid, Spain

[7] Univ Navarra Clin, Dept Hematol, Pamplona, Spain

[8] Univ Navarra, Dept Biochem & Genet, E-31080 Pamplona, Spain

来源：

HAEMATOLOGICA | 2015年 / 100卷 / 05期

关键词：

acute myeloid leukemia; normal karyotype; CIP2; prognosis; overall survival; PROTEIN PHOSPHATASE 2A; SET; MUTATIONS; THERAPY; TARGET; EVENT; CELLS;

D O I：

10.3324/haematol.2014.118117

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 14 条

[1] Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia [J].

Agarwal, Anupriya ;

MacKenzie, Ryan J. ;

Pippa, Raffaella ;

Eide, Christopher A. ;

Oddo, Jessica ;

Tyner, Jeffrey W. ;

Sears, Rosalie ;

Vitek, Michael P. ;

Odero, Maria D. ;

Christensen, Dale J. ;

Druker, Brian J. .

CLINICAL CANCER RESEARCH, 2014, 20 (08) :2092-2103

[2] Treatment of acute myeloid leukemia: are we making progress? [J].

Burnett, Alan K. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, :1-6

[3] CIP2A Is Associated with Human Breast Cancer Aggressivity [J].

Come, Christophe ;

Laine, Anni ;

Chanrion, Maia ;

Edgren, Henrik ;

Mattila, Elina ;

Liu, Xiaoling ;

Jonkers, Jos ;

Ivaska, Johanna ;

Isola, Jorma ;

Darbon, Jean-Marie ;

Kallioniemi, Olli ;

Thezenas, Simon ;

Westermarck, Jukka .

CLINICAL CANCER RESEARCH, 2009, 15 (16) :5092-5100

[4] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect [J].

Cristobal, I. ;

Garcia-Orti, L. ;

Cirauqui, C. ;

Alonso, M. M. ;

Calasanz, M. J. ;

Odero, M. D. .

LEUKEMIA, 2011, 25 (04) :606-614

[5] Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia [J].

Cristobal, Ion ;

Garcia-Orti, Laura ;

Cirauqui, Cristina ;

Cortes-Lavaud, Xabier ;

Garcia-Sanchez, Maria A. ;

Calasanz, Maria J. ;

Odero, Maria D. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (04) :543-550

[6] Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target [J].

Khanna, Anchit ;

Pimanda, John E. ;

Westermarck, Jukka .

CANCER RESEARCH, 2013, 73 (22) :6548-6553

[7] Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1 [J].

Laine, Anni ;

Sihto, Harri ;

Come, Christophe ;

Rosenfeldt, Mathias T. ;

Zwolinska, Aleksandra ;

Niemela, Minna ;

Khanna, Anchit ;

Chan, Edward K. ;

Kahari, Veli-Matti ;

Kellokumpu-Lehtinen, Pirkko-Liisa ;

Sansom, Owen J. ;

Evan, Gerard I. ;

Junttila, Melissa R. ;

Ryan, Kevin M. ;

Marine, Jean-Christophe ;

Joensuu, Heikki ;

Westermarck, Jukka .

CANCER DISCOVERY, 2013, 3 (02) :182-197

[8] c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations [J].

Luo, H ;

Li, C ;

O'Neal, J ;

Kreisel, F ;

Le Beau, MM ;

Tomasson, MH .

BLOOD, 2005, 106 (07) :2452-2461

[9] Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications [J].

Marcucci, Guido ;

Haferlach, Torsten ;

Doehner, Hartmut .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) :475-486

[10] How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia? [J].

Patel, Jay P. ;

Levine, Ross L. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, :28-34

← 1 2 →